Author

J. Mathisen

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Comparing the prevalence of cardiovascular inflammation in women and men with atherosclerotic cardiovascular disease with and without chronic kidney disease: a sub-analysis of the POSEIDON study

Cardiovascular (CV) inflammation, defined as high-sensitivity C-reactive protein (hsCRP) ≥2 mg/L, is often present in individuals with atherosclerotic cardiovascular disease (ASCVD) with or without chronic kidney disease (CKD). However, there are limited data regarding disparities in the prevalence of CV inflamma...

G. Liuzzo, J. Amerena, S. Genth-Zotz et al. · European Heart Journal · 0 citations

Open access Oct 2026

Association between elevated C-reactive protein and mortality, healthcare resource utilization and costs in patients with atherosclerotic cardiovascular disease and/or chronic kidney disease

Atherosclerotic cardiovascular disease (ASCVD) and chronic kidney disease (CKD) impact health and healthcare systems. Inflammation is a potential modifiable risk factor for both conditions. The case for evaluating the modification of inflammation in these conditions could be strengthened by evidence that systemic...

Kausik K. Ray, Fotis Barkas, E. Huisman et al. · European Heart Journal Open · 0 citations

Open access Oct 2026

High sensitivity C-reactive protein and the risk of cardio-kidney outcomes in adults with moderate to severe chronic kidney disease: a nationwide study.

BACKGROUND AND HYPOTHESIS The burden and prognostic significance of inflammation in chronic kidney disease (CKD) remains poorly characterized, with prior studies yielding conflicting estimates of the association between elevated high-sensitivity C-reactive protein (hsCRP) and cardio-kidney outcomes. METHODS Observati...

F. Mazhar, Minjung Han, Katherine R. Tuttle et al. · Nephrology, Dialysis and Tra... · 0 citations